(Q42662953)

4 November 2017

title

Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13. (English)

1 reference

4 November 2017

1 reference

equine infectious anemia

1 reference

equine infectious anemia virus

inferred from title

object named as

equine infectious anemia virus

1 reference

Xu Qi

1

1 reference

4 November 2017

Xuefeng Wang

2

1 reference

4 November 2017

Shuai Wang

3

1 reference

4 November 2017

Yuezhi Lin

4

1 reference

4 November 2017

Chenggang Jiang

5

1 reference

4 November 2017

Jian Ma

6

1 reference

4 November 2017

Liping Zhao

7

1 reference

4 November 2017

Xiaoling Lv

8

1 reference

4 November 2017

Rongxian Shen

9

1 reference

4 November 2017

Fenglong Wang

10

1 reference

4 November 2017

Xiangang Kong

11

1 reference

4 November 2017

Zhiqiang Su

12

1 reference

4 November 2017

Jianhua Zhou

13

1 reference

4 November 2017

publication date

5 June 2010

1 reference

4 November 2017

1 reference

4 November 2017

volume

41

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

86-98

1 reference

Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism

4 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11262-010-0491-6

Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant

21 January 2018

1 reference

12 December 2020

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

1 reference

12 December 2020

Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

1 reference

12 December 2020

Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

1 reference

12 December 2020

Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition

1 reference

12 December 2020

Overlapping synthetic peptides as vaccines

1 reference

12 December 2020

Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.

1 reference

12 December 2020

Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony

1 reference

12 December 2020

Production of equine infectious anemia antigen in a persistently infected cell line

1 reference

12 December 2020

In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine

1 reference

12 December 2020

Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.

1 reference

12 December 2020

Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.

1 reference

12 December 2020

The role of retroviral dUTPases in replication and virulence

1 reference

12 December 2020

Portals of entry: uncovering HIV nuclear transport pathways

1 reference

12 December 2020

Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques

1 reference

12 December 2020

Mutational analysis of the equine infectious anemia virus Tat-responsive element

1 reference

12 December 2020

Viral DNA in horses infected with equine infectious anemia virus

1 reference

12 December 2020

Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.

1 reference

12 December 2020

Diversity considerations in HIV-1 vaccine selection

1 reference

12 December 2020

Equine infectious anemia: current knowledge

1 reference

12 December 2020

A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses

1 reference

12 December 2020

The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro

1 reference

12 December 2020

Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?

1 reference

12 December 2020

Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus

1 reference

12 December 2020

Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages

1 reference

12 December 2020

Immunopathology of equine infectious anemia

1 reference

12 December 2020

Envelope variation as a primary determinant of lentiviral vaccine efficacy

1 reference

12 December 2020

Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain

1 reference

12 December 2020

Structural features of the trans-activation response RNA element of equine infectious anemia virus

1 reference

12 December 2020

Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases

1 reference

12 December 2020

Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities

1 reference

12 December 2020

Biological characterization of Rev variation in equine infectious anemia virus

1 reference

12 December 2020

HIV vaccine design: insights from live attenuated SIV vaccines

1 reference

12 December 2020

Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus

1 reference

12 December 2020

Virulence determinants of equine infectious anemia virus

1 reference

12 December 2020

1 reference

12 December 2020

NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus

1 reference

12 December 2020

Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication,

1 reference

12 December 2020

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.

1 reference

12 December 2020

Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2

1 reference

12 December 2020

Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

1 reference

12 December 2020

Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies

1 reference

12 December 2020

Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence

1 reference

12 December 2020

The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies

1 reference

12 December 2020

10.1007/S11262-010-0491-6

Identifiers

DOI

1 reference

Dimensions Publication ID

4 November 2017

1030877925

0 references

1 reference